Total Payments
$74,888
2024 Payments
$542.69
Companies
19
Transactions
232
Medicare Patients
7,439
Medicare Billing
$657,204
Payment Breakdown by Category
Research$70,426 (94.0%)
Food & Beverage$4,263 (5.7%)
Other$150.00 (0.2%)
Education$49.95 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $70,426 | 49 | 94.0% |
| Food and Beverage | $4,263 | 180 | 5.7% |
| Honoraria | $150.00 | 1 | 0.2% |
| Education | $49.95 | 2 | 0.1% |
Payments by Type
Research
$70,426
49 transactions
General
$4,462
183 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Ichnos Sciences Inc. | $58,324 | 28 | $0 (2021) |
| Eli Lilly and Company | $10,940 | 1 | $0 (2019) |
| Glenmark Pharmaceuticals Inc. | $1,161 | 20 | $0 (2019) |
| Janssen Biotech, Inc. | $940.65 | 88 | $0 (2024) |
| PFIZER INC. | $798.82 | 26 | $0 (2022) |
| AbbVie Inc. | $629.85 | 7 | $0 (2020) |
| LEO Pharma Inc. | $518.52 | 24 | $0 (2023) |
| GENZYME CORPORATION | $337.20 | 7 | $0 (2021) |
| EPI Health, LLC | $312.93 | 2 | $0 (2018) |
| Incyte Corporation | $169.50 | 8 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $542.69 | 26 | Janssen Biotech, Inc. ($314.33) |
| 2023 | $544.26 | 34 | Janssen Biotech, Inc. ($248.97) |
| 2022 | $1,033 | 52 | LEO Pharma Inc. ($296.17) |
| 2021 | $35,109 | 15 | Ichnos Sciences Inc. ($34,789) |
| 2020 | $23,658 | 24 | Ichnos Sciences Inc. ($23,536) |
| 2019 | $12,418 | 28 | Eli Lilly and Company ($10,940) |
| 2018 | $1,212 | 29 | EPI Health, LLC ($312.93) |
| 2017 | $371.05 | 24 | AbbVie, Inc. ($195.76) |
All Payment Transactions
232 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $21.22 | General |
| Category: Immunology | ||||||
| 12/02/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $11.43 | General |
| Category: Immunology | ||||||
| 11/25/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $5.94 | General |
| Category: Immunology | ||||||
| 11/18/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $14.28 | General |
| Category: Immunology | ||||||
| 11/05/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $14.22 | General |
| Category: Immunology | ||||||
| 10/16/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPEVIGO (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: IMMUNOLOGY | ||||||
| 08/26/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $41.69 | General |
| Category: Immunology | ||||||
| 07/09/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $23.03 | General |
| Category: Immunology | ||||||
| 07/05/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $10.91 | General |
| Category: Immunology | ||||||
| 06/27/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $6.67 | General |
| Category: Immunology | ||||||
| 06/25/2024 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $25.27 | General |
| Category: Immunology | ||||||
| 06/21/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $33.43 | General |
| Category: Immunology | ||||||
| 06/14/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $6.13 | General |
| Category: Immunology | ||||||
| 06/03/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $9.33 | General |
| Category: Immunology | ||||||
| 05/28/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $19.12 | General |
| Category: Immunology | ||||||
| 05/16/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $16.64 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 05/16/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $5.60 | General |
| Category: Immunology | ||||||
| 05/16/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $0.88 | General |
| Category: Immunology | ||||||
| 04/25/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $9.45 | General |
| Category: Immunology | ||||||
| 04/02/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $16.94 | General |
| Category: Immunology | ||||||
| 03/14/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $16.73 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 03/05/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $27.52 | General |
| Category: Immunology | ||||||
| 03/01/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $9.46 | General |
| Category: Immunology | ||||||
| 02/03/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $11.35 | General |
| Category: Immunology | ||||||
| 01/30/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $29.95 | General |
| Category: Immunology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| GBR830-204 | Ichnos Sciences Inc. | $58,324 | 28 |
| A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 3 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF BARICITINIB IN ADULT PATIENTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS | Eli Lilly and Company | $10,940 | 1 |
| A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study Investigating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of GBR830 Administered to Adult Subjects with Moderate-to-Severe Atopic Dermatitis (AD) | Glenmark Pharmaceuticals Inc. | $1,161 | 20 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 1,767 | 2,990 | $465,308 | $156,731 |
| 2022 | 11 | 1,843 | 3,207 | $497,279 | $167,863 |
| 2021 | 13 | 1,939 | 3,517 | $529,237 | $183,725 |
| 2020 | 10 | 1,890 | 3,533 | $487,402 | $148,884 |
Total Patients
7,439
Total Services
13,247
Medicare Billing
$657,204
Procedure Codes
45
All Medicare Procedures & Services
45 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 700 | 1,165 | $174,625 | $76,825 | 44.0% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 225 | 347 | $69,400 | $16,967 | 24.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 234 | 374 | $34,933 | $15,532 | 44.5% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 156 | 183 | $50,325 | $14,309 | 28.4% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 122 | 148 | $44,400 | $13,363 | 30.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 116 | 116 | $25,520 | $8,915 | 34.9% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 23 | 27 | $9,450 | $3,662 | 38.8% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 140 | 578 | $46,240 | $3,342 | 7.2% |
| 17272 | Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | Office | 2023 | 12 | 12 | $4,500 | $1,824 | 40.5% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 21 | 21 | $3,255 | $1,229 | 37.8% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 18 | 19 | $2,660 | $761.62 | 28.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 701 | 1,164 | $174,600 | $77,937 | 44.6% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 220 | 386 | $77,200 | $18,450 | 23.9% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 179 | 211 | $58,025 | $17,116 | 29.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 265 | 391 | $36,404 | $17,009 | 46.7% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 130 | 154 | $46,200 | $14,656 | 31.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 143 | 143 | $31,460 | $11,598 | 36.9% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 135 | 683 | $54,640 | $3,921 | 7.2% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2022 | 19 | 23 | $8,050 | $3,186 | 39.6% |
| 17281 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm | Office | 2022 | 15 | 15 | $5,250 | $2,245 | 42.8% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 18 | 19 | $2,660 | $877.61 | 33.0% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 18 | 18 | $2,790 | $867.21 | 31.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 739 | 1,247 | $181,033 | $86,250 | 47.6% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2021 | 222 | 262 | $72,050 | $22,395 | 31.1% |
| 17000 | Destruction of skin growth | Office | 2021 | 229 | 392 | $78,400 | $19,394 | 24.7% |
About Dr. William Notaro, MD
Dr. William Notaro, MD is a Dermatology healthcare provider based in Danbury, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1144255332.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. William Notaro, MD has received a total of $74,888 in payments from pharmaceutical and medical device companies, with $542.69 received in 2024. These payments were reported across 232 transactions from 19 companies. The most common payment nature is "" ($70,426).
As a Medicare-enrolled provider, Notaro has provided services to 7,439 Medicare beneficiaries, totaling 13,247 services with total Medicare billing of $657,204. Data is available for 4 years (2020–2023), covering 45 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Danbury, CT
- Active Since 07/12/2006
- Last Updated 06/27/2008
- Taxonomy Code 207N00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1144255332
Products in Payments
- GBR830-204 (Drug) $23,536
- TREMFYA (Drug) $729.28
- EUCRISA (Drug) $679.90
- ADBRY (Biological) $450.48
- Humira (Biological) $439.69
- DUPIXENT (Biological) $335.21
- Bensal HP (Drug) $312.93
- OPZELURA (Drug) $169.50
- Otezla (Drug) $168.60
- DUPIXENT (Drug) $151.01
- REMICADE (Biological) $134.40
- Tremfya (Drug) $127.96
- SPEVIGO (Drug) $125.00
- CIBINQO (Drug) $118.92
- SKYRIZI (Biological) $106.70
- STELARA (Biological) $99.01
- ENSTILAR (Drug) $68.04
- TALTZ (Drug) $58.91
- Klisyri (Drug) $32.12
- Sotyktu (Drug) $30.50
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Danbury
Ms. Mona Gohara, Md, MD
Dermatology — Payments: $243,572
Dermatology $243,572
Mr. Graeme Lipper, Md, MD
Dermatology — Payments: $26,582
Dermatology $26,582
Mr. Jonathan Zirn, Md, MD
Dermatology — Payments: $15,406
Dermatology $15,406
Ms. Grace Federman, Md, MD
Dermatology — Payments: $11,380
Dermatology $11,380
Dr. Marimeg Clairwood, M.d, M.D
Dermatology — Payments: $5,407
Dermatology $5,407
Dmitriy Timerman
Dermatology — Payments: $4,673
Dermatology $4,673